Results 11 to 20 of about 1,383,024 (290)

Staging of Skin Cancer Based on Hyperspectral Microscopic Imaging and Machine Learning

open access: yesBiosensors, 2022
Skin cancer, a common type of cancer, is generally divided into basal cell carcinoma (BCC), squamous cell carcinoma (SCC) and malignant melanoma (MM). The incidence of skin cancer has continued to increase worldwide in recent years.
Lixin Liu   +6 more
doaj   +1 more source

Breast cancer classification

open access: yes, 2021
Breast cancer is most frequently diagnosed cancer and the second most frequent cause of death in women. Early detection and treatment is the key for the patient’s health and reduced mortality. Machine learning classification can be used to help physicians in early diagnosis and classification of breast tumours. In this paper, three types of classifiers
Manpreet Singh Katari   +2 more
  +5 more sources

OPTIMIZING ULTRASOUND IMAGE CLASSIFICATION THROUGH TRANSFER LEARNING: FINE-TUNING STRATEGIES AND CLASSIFIER IMPACT ON PRE-TRAINED INNER-LAYERS

open access: yesInformatyka, Automatyka, Pomiary w Gospodarce i Ochronie Środowiska, 2023
Transfer Learning (TL) is a popular deep learning technique used in medical image analysis, especially when data is limited. It leverages pre-trained knowledge from State-Of-The-Art (SOTA) models and applies it to specific applications through Fine ...
Mohamed Bal-Ghaoui   +3 more
doaj   +1 more source

Pan-cancer classifications of tumor histological images using deep learning [PDF]

open access: yes, 2020
Histopathological images are essential for the diagnosis of cancer type and selection of optimal treatment. However, the current clinical process of manual inspection of images is time consuming and prone to intra- and inter-observer variability. Here we
Caruana, Dennis   +8 more
core   +1 more source

A Hierarchical Feature-Based Methodology to Perform Cervical Cancer Classification

open access: yesApplied Sciences, 2021
Prevention of cervical cancer could be performed using Pap smear image analysis. This test screens pre-neoplastic changes in the cervical epithelial cells; accurate screening can reduce deaths caused by the disease.
Débora N. Diniz   +6 more
doaj   +1 more source

A Novel Electrochemical Differentiation between Exosomal-RNA of Breast Cancer MCF7 and MCF7/ADR-Resistant Cells

open access: yesPharmaceuticals, 2023
Cancer is considered one of the most burdensome diseases affecting lives and, hence, the economy. Breast cancer is one of the most common types of cancer.
Mohammed H. Abdelaziz   +2 more
doaj   +1 more source

A Framework to Discover Emerging Patterns for Application in Microarray Data [PDF]

open access: yes, 2003
Various supervised learning and gene selection methods have been used for cancer diagnosis. Most of these methods do not consider interactions between genes, although this might be interesting biologically and improve classification accuracy.
Boulesteix, Anne-Laure, Tutz, Gerhard
core   +3 more sources

Classification of Parathyroid Cancer

open access: yesAnnals of Surgical Oncology, 2012
Parathyroid cancer is rare and often has a poor outcome. There is no classification system that permits prediction of outcome in patients with parathyroid cancer. This study was designed to validate two prognostic classification systems developed by Talat and Schulte in 2010 ("Clinical Presentation, Staging and Long-term Evolution of Parathyroid Cancer,
Schulte, K   +9 more
openaire   +4 more sources

Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women [PDF]

open access: yes, 2016
microRNAs (miRNAs) play an important role in cancer prognosis. They are small molecules, approximately 17–25 nucleotides in length, and their high stability in human serum supports their use as novel diagnostic biomarkers of cancer and other pathological
El Masry, Maha Rafik   +4 more
core   +1 more source

The consensus Immunoscore in phase 3 clinical trial (N0147) and impact on patient management decisions

open access: yesOncoImmunology, 2020
The consensus Immunoscore is a routine assay quantifying the adaptive immune response within the tumor microenvironment. It has a prognostic value that has been confirmed in a phase 3 clinical trial (NCCTG N0147) in stage III colon cancers.
Anastasia Lanzi   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy